# Observational recurrence studies recruiting: 100 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 100 trials that are observational for recurrence that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational recurrence studies: 100 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 3 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/recurrence

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 100
- Recruiting or not yet: 100
- Read on: November 19, 2026

## Trials

The 25 newest of 100, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07946393 | Preoperative CA 19-9 and the Pattern and Timing of Recurrence After Pancreatoduodenectomy (Whipple Operation) for Pancreatic Cancer | Minia University | Observational | Not yet recruiting | Pancreatic Ductal Adenocarcinoma, Pancreatic Neoplasms, Neoplasm Recurrence, Local, Neoplasm Metastasis | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946393) |
| October 27, 2026 | NCT07898436 | Menin Inhibitors in Pediatric Relapsed or Refractory Acute Leukemia | University Hospital, Strasbourg, France | Observational | Recruiting | Acute Leukemia, Relapsed or Refractory Pediatric Leukemia, KMT2A-rearranged, NUP98-rearranged, or NPM1-mutated... | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07898436) |
| October 1, 2026 | NCT07853378 | Incidence and Predictors of Early Clinical Relapse Within Six Months After Thymectomy in Patients With Myasthenia Gravis | Assiut University | Observational | Not yet recruiting | Myasthenia Gravis, Thymoma | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07853378) |
| September 24, 2026 | NCT07840092 | Biomarker Validation for Treatment Efficacy and Recurrence Prediction in Hepatocellular Carcinoma | Tianjin Medical University Cancer Institute and Hospital | Observational | Recruiting | Hepatocellular Carcinoma (HCC) | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07840092) |
| September 24, 2026 | NCT07839767 | Treatment Selection by 3D Bioprinting Liver Model to Prevent Liver Cancer Recurrence | The University of Hong Kong | Observational | Recruiting | HCC - Hepatocellular Carcinoma | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07839767) |
| September 24, 2026 | NCT07838207 | Prognosis and Therapeutic Implications in Molecular High-Risk Non-Myoinvasive Endometrial Cancer | Hospital Universitari Vall d'Hebron Research Institute | Observational | Recruiting | Endometrial Cancer, Endometrial Carcinoma (EC), p53abn | 350 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07838207) |
| September 4, 2026 | NCT07804875 | Symptom Trajectory Approaches to Research | University of Wisconsin, Madison | Observational | Not yet recruiting | Advanced Cancer, Metastatic Disease, Cancer Treatment, Progressive Disease, Recurrent Cancer | 228 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07804875) |
| August 24, 2026 | NCT07782164 | Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study) | Amsterdam UMC, location VUmc | Observational | Recruiting | Colorectal Carcinoma, Renal Cancer, Bladder Cancer, Cervical Cancer, Prostate Cancer, Ovarian Cancer, Lung Cancer... | 27 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07782164) |
| August 19, 2026 | NCT07773285 | Validation of the G8 Screening Tool for Prognostic Assessment of Frailty and Early Mortality in Elderly Individuals With Cancer... | Latin American Cooperative Oncology Group | Observational | Recruiting | Solid Tumor, Metastatic Solid Tumor, Recurrent Solid Tumor | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07773285) |
| July 10, 2026 | NCT07695896 | Real-World Study of Bispecific Antibody in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma | Sponsor not shown (see the record) | Observational | Not yet recruiting | Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07695896) |
| July 10, 2026 | NCT07694674 | Comparison of the Efficacy of Different Biologic Agents in Preventing Postoperative Endoscopic Recurrence of Crohn's Disease | Shanghai 10th People's Hospital | Observational | Recruiting | Inflamatory Bowel Disease, Crohn Disease (CD) | 198 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07694674) |
| June 25, 2026 | NCT07669194 | Glofitamab Combined With Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma | Second Affiliated Hospital, Zhejiang University, School of Medicine | Observational | Not yet recruiting | Diffuse Large B-Cell Lymphoma (DLBCL) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07669194) |
| June 17, 2026 | NCT07652983 | TTE Study of QL1706 in Recurrent/Metastatic Cervical Cancer | Qilu Hospital of Shandong University | Observational | Not yet recruiting | Recurrent or Metastatic Cervical Cancer | 280 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07652983) |
| June 10, 2026 | NCT07637929 | Non-Interventional Study of Puzol-cel for CD19-Positive Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia | Chongqing Precision Biotech Co., Ltd | Observational | Not yet recruiting | Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia (r/r B-ALL) | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07637929) |
| June 9, 2026 | NCT07636148 | Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance | Sponsor not shown (see the record) | Observational | Recruiting | Liver Cancer (Primary and Metastatic), Lung Cancer (Diagnosis), Bone Cancer Metastatic, Bone Cancer Tumor, Kidney... | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07636148) |
| May 28, 2026 | NCT07611838 | Multi-Omics Inflammatory Phenotype for ABPA Recurrence Risk Prediction | Qianfoshan Hospital | Observational | Recruiting | Allergic Bronchopulmonary Aspergillosis (ABPA), Machine Learning, Multi-omics, Multicenter Study, Relapse | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07611838) |
| May 15, 2026 | NCT07589413 | Association Between Irrigation Fluid Absorption and Perioperative cfDNA Dynamics After TURBT | Sponsor not shown (see the record) | Observational | Recruiting | Bladder (Urothelial, Transitional Cell) Cancer, Bladder Cancer Recurrence, Progression of Bladder Cancer, Transurethral... | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07589413) |
| May 7, 2026 | NCT07572695 | Salvage Haploidentical HSCT With DLI and Targeted Therapy for R/R AML | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Observational | Not yet recruiting | Acute Myeloid Leukemia, Relapsed/Refractory Acute Myeloid Leukemia, AML, Relapsed/Refractory | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07572695) |
| May 6, 2026 | NCT07570407 | Quantification of Peripheral Blood iNKTs After Allogeneic Stem Cell Transplantation | University Hospital Pilsen | Observational | Recruiting | Allogeneic HSCT, Posttransplant Complications, GvHD, Relapse, Acute Myeloid Leukemia | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07570407) |
| April 20, 2026 | NCT07540403 | Survival Analysis in patiEnts With Bad Prognosis Epithelial Ovarian CArcinoma | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Recruiting | Ovarian Cancer | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07540403) |
| April 13, 2026 | NCT07526298 | Anticipating Irreversible Disability in Neuromyelitis Optica Spectrum Disorder: a Study to Assess Disease Activity in Apparently Stable... | IRCCS San Raffaele | Observational | Not yet recruiting | Neuromyelitis Optica Spectrum Disorders | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07526298) |
| March 20, 2026 | NCT07486440 | Shoulder Dislocation: Assessment of Lesions, Trajectories and Outcomes (SALTO) | Oslo University Hospital | Observational | Not yet recruiting | Anterior Shoulder Dislocation, Shoulder Dislocation Closed Traumatic, First Time Shoulder Dislocation, Shoulder... | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07486440) |
| March 20, 2026 | NCT07484763 | Predicting Recurrence in HR+/HER2- Early Breast Cancer | Shengjing Hospital | Observational | Not yet recruiting | Breast Cancer, HR+/HER2- Early-Stage | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07484763) |
| March 16, 2026 | NCT07472972 | Dynamic Individualized Risk Profiling of Patients With Relapsed/Refractory Lymphoid Malignancies and CD19-CAR T Cell Therapy (INTeRCePT 2.0) | University of Zurich | Observational | Recruiting | Lymphoma, Lymphoid Hematological Malignancies | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07472972) |
| March 13, 2026 | NCT07470294 | Effectiveness of Different Surgical Techniques for Curative Treatment of Pilonidal Sinus Disease in the Pediatric Population | University Hospital, Angers | Observational | Not yet recruiting | Sacrococcygeal Pilonidal Sinus | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07470294) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Tongji Hospital | 3 |
| Memorial Sloan Kettering Cancer Center | 3 |
| IRCCS San Raffaele | 3 |
| City of Hope Medical Center | 2 |
| Tata Memorial Hospital | 2 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2 |
| Peking University Third Hospital | 2 |
| Urological Research Network, LLC | 2 |
| Erasmus Medical Center | 2 |
| Zhujiang Hospital | 2 |
| Universitaire Ziekenhuizen KU Leuven | 2 |
| Yonsei University | 1 |
| Samsung Medical Center | 1 |
| Latin American Cooperative Oncology Group | 1 |
| Qianfoshan Hospital | 1 |
| University Hospital, Lille | 1 |
| University of Michigan | 1 |
| Hospital for Special Surgery, New York | 1 |
| Shanghai Chest Hospital | 1 |
| Chung Shan Medical University | 1 |
| Children's Oncology Group | 1 |
| Fudan University | 1 |
| Assiut University | 1 |
| Gruppo Oncologico Italiano di Ricerca Clinica | 1 |
| Huazhong University of Science and Technology | 1 |

## By country

| Country | Trials |
| --- | --- |
| China | 25 |
| United States | 17 |
| Italy | 10 |
| France | 7 |
| South Korea | 4 |
| Canada | 3 |
| Germany | 3 |
| Netherlands | 3 |
| Belgium | 3 |
| Japan | 2 |
| India | 2 |
| Australia | 2 |
| Poland | 2 |
| Switzerland | 2 |
| Spain | 2 |
| Brazil | 1 |
| Taiwan | 1 |
| Puerto Rico | 1 |
| Norway | 1 |
| Czechia | 1 |
| Austria | 1 |
| Egypt | 1 |
| New Zealand | 1 |
| Finland | 1 |
| Hong Kong | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Surgical supply companies in the United States](https://specstream.ai/data/businesses/surgical-supply-companies/united-states)
- [Financial services firms in the United States](https://specstream.ai/data/businesses/financial-services-firms/united-states)
- [T-shirt printers in the United States](https://specstream.ai/data/businesses/t-shirt-printers/united-states)
- [Fire protection companies in the United States](https://specstream.ai/data/businesses/fire-protection-companies/united-states)
- [Taiwanese restaurants in the United States](https://specstream.ai/data/businesses/taiwanese-restaurants/united-states)
- [Fitness equipment wholesalers in the United States](https://specstream.ai/data/businesses/fitness-equipment-wholesalers/united-states)
